Tan, C. L. http://orcid.org/0000-0002-2529-1030
Lindner, K. http://orcid.org/0000-0002-2735-3266
Boschert, T.
Meng, Z. http://orcid.org/0000-0002-6690-7380
Rodriguez Ehrenfried, A.
De Roia, A.
Haltenhof, G.
Faenza, A.
Imperatore, F. http://orcid.org/0000-0001-5883-4727
Bunse, L. http://orcid.org/0000-0002-4490-7574
Lindner, J. M. http://orcid.org/0000-0002-4940-5354
Harbottle, R. P.
Ratliff, M. http://orcid.org/0000-0002-9464-6544
Offringa, R.
Poschke, I. http://orcid.org/0000-0002-4387-5566
Platten, M. http://orcid.org/0000-0002-4746-887X
Green, E. W. http://orcid.org/0000-0003-1922-2298
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (404521405, 259332240)
Article History
Received: 13 June 2023
Accepted: 1 February 2024
First Online: 7 March 2024
Competing interests
: C.L.T., K.L., Z.M., A.R.E., R.O., L.B., M.P. and E.W.G. are inventors on patent applications describing the identification of tumor-reactive TCRs. M.P., R.P.H., R.O. and E.W.G. are founders of Tcelltech GmbH. A.F. and F.I. are employees of Cellply Srl. J.M.L. is an employee of BioMed X GmbH. The other authors declare no competing interests.